Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN. Anand IS, et al. Among authors: sabolinski ml. J Am Coll Cardiol. 2007 Jan 2;49(1):32-9. doi: 10.1016/j.jacc.2006.04.109. Epub 2006 Dec 14. J Am Coll Cardiol. 2007. PMID: 17207719 Free article.
Outcomes by gender in the African-American Heart Failure Trial.
Taylor AL, Lindenfeld J, Ziesche S, Walsh MN, Mitchell JE, Adams K, Tam SW, Ofili E, Sabolinski ML, Worcel M, Cohn JN; A-HeFT Investigators. Taylor AL, et al. Among authors: sabolinski ml. J Am Coll Cardiol. 2006 Dec 5;48(11):2263-7. doi: 10.1016/j.jacc.2006.06.020. Epub 2006 Nov 9. J Am Coll Cardiol. 2006. PMID: 17161257 Free article.
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. Taylor AL, et al. Among authors: sabolinski ml. Circulation. 2007 Apr 3;115(13):1747-53. doi: 10.1161/CIRCULATIONAHA.106.644013. Epub 2007 Mar 19. Circulation. 2007. PMID: 17372175 Clinical Trial.
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
Yancy CW, Ghali JK, Braman VM, Sabolinski ML, Worcel M, Archambault WT, Franciosa JA. Yancy CW, et al. Among authors: sabolinski ml. Am J Cardiol. 2007 Aug 15;100(4):684-9. doi: 10.1016/j.amjcard.2007.03.086. Epub 2007 Jun 26. Am J Cardiol. 2007. PMID: 17697829 Clinical Trial.
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators. Ghali JK, et al. Among authors: sabolinski ml. Am J Cardiovasc Drugs. 2007;7(5):373-80. doi: 10.2165/00129784-200707050-00007. Am J Cardiovasc Drugs. 2007. PMID: 18041162 Clinical Trial.
34 results